Next Breath Announces Injectable, Extractable and Leachable Services

Jan 19, 2018

Next Breath, a division of AptarGroup, Inc., is pleased to announce the extension of their cGMP analytical services to include development services for injectable delivery systems, with a core focus on extractables and leachables (E&L). Next Breath will be highlighting their new services at the upcoming drug delivery and packaging conference, Pharmapack, held on February 7-8, 2018 in Paris, France.   For over 16 years, Next Breath has offered a wide array of dedicated analytical services for inhalation and nasal drug development while providing support for global regulatory strategy. This recent addition of services for injectable delivery comes as a ...

Read More

RDD 2018: Early Registration Deadline January 22

Jan 16, 2018

Now’s The Time to Plan to Participate, Register & Save.This readily accessible, major international symposium is where nasal and pulmonary product developers innovate and network with their suppliers and regulators in business-friendly surroundings. Respiratory Drug Delivery (RDD®) 2018. Where: JW Marriott Starr Pass Resort & Spa, Tucson, Arizona; When: April 22-26, 2018. Register for RDD 2018. Discounts available until January 22, 2018. View the Full Scientific Program including a special session on Expanding the Marketplace for Generic Inhalers via Improved Testing & Regulatory Guidance. RDD 2018 includes our signature Scientific Poster and Technology Exhibition, offering excellent opportunities to present your new products and ideas ...

Read More

Pulmonary and Nasal Drug Delivery Experts to Attend ASAL RDD Europe 2017

Jan 9, 2018

Register now to attend the RDD Europe 2017 Scientific Conference to be held April 25-28, 2017, in Antibes, France. The Respiratory Drug Delivery (RDD®) Europe 2017 scientific conference will welcome pulmonary and nasal drug delivery experts from around the world to Antibes, France, April 25-28, 2017. The joint organizers of this event, RDD Online® and Aptar Pharma invite you to register at www.rddonline. com/rddeurope2017. Bringing the Respiratory World Together Respiratory Drug Delivery Europe is a major conference bringing together experts from around the world to exchange emerging scientific knowledge and providing a dynamic forum for business networking. Approximately 450 delegates ...

Read More

Phillips-Medisize Creates a Manufacturing Center of Excellence for Connected Health and Drug Delivery Devices

Dec 7, 2017

Phillips-Medisize, a Molex company, announces its initial investment to expand the capabilities of the 380,000 square foot Molex Little Rock facility to include a FDA registered manufacturing Center of Excellence for Connected Health and drug delivery devices. The construction of purpose-built clean room suites, as well as FDA registration and ISO 13485 certification are scheduled to be complete for its first customer’s production beginning in Q2 2018. This facility establishes a new manufacturing site in Little Rock, Arkansas for Phillips-Medisize’s medical business with capabilities for filling, drug handling, electronics and connected devices. This investment aims to combine the innovative solutions ...

Read More

Phillips-Medisize Exhibits During DDL2017

Nov 28, 2017

Phillips-Medisize will exhibit at the Drug Delivery to the Lungs Conference, which is taking place at Edinburgh International Conference Center on December 6-8, 2017. DDL is Europe’s premier conference and exhibition dedicated to pulmonary and nasal drug delivery. Treating and monitoring chronic respiratory diseases such as asthma, where patients can self-administer today with established dry powder inhalers (DPIs) and metered dose inhalers (MHIs), as well as more recent soft mist inhalers (SMIs) is another theme during DDL. As the development partner of the first DPI, and being involved in the development of various inhaler programs, Phillips-Medisize has been at the ...

Read More